DexCom, Inc.

DXCM

$66.37

Name : DexCom, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $26,027,345,920.00

EPSttm : 1.8

DexCom, Inc.

$66.37

1.03%

$0.69

Float Short %

3.41

Margin Of Safety %

Put/Call OI Ratio

0.67

EPS Next Q Diff

-0.14

EPS Last/This Y

0.6

EPS This/Next Y

0.41

Price

66.38

Target Price

86.42

Analyst Recom

1.42

Performance Q

0.44

Relative Volume

0.35

Beta

1.49

Ticker: DXCM

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-02	DXCM	64.45	0.68	0.84	191532
2025-12-03	DXCM	64.83	0.68	2.61	193897
2025-12-04	DXCM	65.27	0.68	10.25	194006
2025-12-05	DXCM	65.5	0.67	1.07	195049
2025-12-08	DXCM	65.65	0.67	4.48	194015
2025-12-09	DXCM	66.32	0.66	1.08	194802
2025-12-10	DXCM	67.54	0.66	1.14	195978
2025-12-11	DXCM	68.93	0.66	2.28	196684
2025-12-12	DXCM	66.94	0.67	1.67	197886
2025-12-15	DXCM	65.71	0.67	0.86	196411
2025-12-16	DXCM	66.38	0.67	0.76	197177
2025-12-17	DXCM	65.76	0.67	0.27	198127
2025-12-18	DXCM	65.88	0.67	2.35	199426
2025-12-19	DXCM	66.04	0.67	0.61	199870
2025-12-22	DXCM	67.4	0.66	0.42	178160
2025-12-23	DXCM	66.85	0.66	0.38	180092
2025-12-26	DXCM	67.57	0.67	0.85	182272
2025-12-29	DXCM	67.5	0.67	0.34	180376
2025-12-30	DXCM	67.08	0.68	5.21	181699
2025-12-31	DXCM	66.39	0.67	0.89	181079
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-02	DXCM	64.45	43.8	-9.4	2.07
2025-12-03	DXCM	64.85	43.8	-17.7	2.07
2025-12-04	DXCM	65.28	43.8	-17.4	2.07
2025-12-05	DXCM	65.49	44.0	-20.2	2.07
2025-12-08	DXCM	65.62	44.0	-	2.07
2025-12-09	DXCM	66.33	44.0	-13.2	2.07
2025-12-10	DXCM	66.33	44.0	-5.8	2.07
2025-12-11	DXCM	68.94	44.0	-3.7	2.07
2025-12-12	DXCM	66.96	44.0	-52.0	2.07
2025-12-15	DXCM	65.73	44.0	-41.8	2.07
2025-12-16	DXCM	65.73	43.8	-14.1	2.06
2025-12-17	DXCM	65.76	43.8	-32.7	2.06
2025-12-18	DXCM	65.89	43.8	-21.7	2.06
2025-12-19	DXCM	66.04	43.8	-21.8	2.06
2025-12-22	DXCM	67.55	43.8	-1.2	2.06
2025-12-23	DXCM	66.85	43.8	-32.2	2.06
2025-12-26	DXCM	67.57	43.8	-21.6	2.06
2025-12-29	DXCM	67.50	43.8	-24.9	2.06
2025-12-30	DXCM	67.06	43.8	-29.8	2.06
2025-12-31	DXCM	66.38	43.8	-33.8	2.06
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-02	DXCM	-0.27	0.98	3.49
2025-12-03	DXCM	-0.27	0.98	3.49
2025-12-04	DXCM	-0.27	0.98	3.49
2025-12-05	DXCM	-0.27	0.98	3.49
2025-12-08	DXCM	-0.27	1.02	3.49
2025-12-09	DXCM	-0.28	1.02	3.49
2025-12-10	DXCM	-0.28	1.02	3.39
2025-12-11	DXCM	-0.28	1.02	3.39
2025-12-12	DXCM	-0.28	1.02	3.39
2025-12-15	DXCM	-0.28	1.02	3.39
2025-12-16	DXCM	-0.27	1.02	3.39
2025-12-17	DXCM	-0.27	1.02	3.39
2025-12-18	DXCM	-0.16	1.02	3.39
2025-12-19	DXCM	-0.11	1.02	3.39
2025-12-22	DXCM	-0.11	1.98	3.39
2025-12-23	DXCM	-0.11	1.98	3.39
2025-12-26	DXCM	-0.11	1.98	3.41
2025-12-29	DXCM	-0.11	1.89	3.41
2025-12-30	DXCM	-0.11	1.89	3.41
2025-12-31	DXCM	-0.11	1.89	3.41
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.61

Avg. EPS Est. Current Quarter

0.65

Avg. EPS Est. Next Quarter

0.47

Insider Transactions

-0.11

Institutional Transactions

1.89

Beta

1.49

Average Sales Estimate Current Quarter

1240

Average Sales Estimate Next Quarter

1178

Fair Value

74.24

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

59.7

Max Drawdown 5-Year %

-66.3

Target Price

86.42

P/E

36.94

Forward P/E

26.84

PEG

1.22

P/S

5.73

P/B

9.49

P/Free Cash Flow

24.38

EPS

1.8

Average EPS Est. Cur. Y

2.06

EPS Next Y. (Est.)

2.48

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

15.96

Relative Volume

0.35

Return on Equity vs Sector %

-0.8

Return on Equity vs Industry %

8.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-33.8

DexCom, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 10200

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Stelo, a new over-the-counter glucose biosensor designed for adults with prediabetes and Type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

stock quote shares DXCM – DexCom, Inc. Stock Price stock today

news today DXCM – DexCom, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch DXCM – DexCom, Inc. yahoo finance google finance

stock history DXCM – DexCom, Inc. invest stock market

stock prices DXCM premarket after hours

ticker DXCM fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: DXCM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y